All Questions are Mandatory!
-
1.Prescriptions of Clarus® for women of child-bearing potential should be limited to ___ days of treatment.
-
2.Continuation of treatment requires a new prescription.
-
3.Pregnancy testing, issuing a prescription and dispensing of Clarus® should occur on the same day.
-
4.Dispensing of Clarus® should occur within a maximum of ___ days of the prescription.
-
5.Have you referred patients to the toll-free number 1- 877-776-7711 or the Clarus® CLEARTM Program Website for more information about birth control or for counselling?
-
6.How do you access Mylan Pharmaceuticals ULC’s Clinical Education and Awareness Resource (CLEARTM)?
-
7.The patient must have ___ negative pregnancy tests before starting Clarus® therapy with the first pregnancy test conducted at initial assessment.
-
8.Pregnancy tests must be repeated at one month after discontinuation of treatment.
-
9.Clarus® should be stored at controlled room temperature (15°C to 30°C). Store in the original package. Protect from exposure to heat and light. Clarus® does not need to be refrigerated.
-
10.Patients should take Clarus® with food or just after a meal.
-
11.Which of the following is an important identified risk of Clarus®?